- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 498/16 - Peri-condensed systems
Patent holdings for IPC class C07D 498/16
Total number of patents in this class: 195
10-year publication summary
|
21
|
14
|
14
|
12
|
8
|
19
|
15
|
16
|
19
|
13
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3689 |
11 |
| Merck Patent GmbH | 5909 |
10 |
| Genentech, Inc. | 3742 |
8 |
| ImmunoGen, Inc. | 405 |
8 |
| Bristol-myers Squibb Company | 5080 |
7 |
| Gilead Pharmasset LLC | 43 |
6 |
| Gilead Sciences, Inc. | 1879 |
6 |
| Incyte Holdings Corporation | 609 |
6 |
| Lupin Limited | 448 |
5 |
| Turning Point Therapeutics, Inc. | 97 |
5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 616 |
4 |
| Universal Display Corporation | 1678 |
4 |
| Bayer AG | 3045 |
3 |
| The Board of Trustees of the University of Illinois | 2623 |
3 |
| The Broad Institute, Inc. | 1584 |
3 |
| CTI Biopharma Corp. | 56 |
3 |
| OCERA Therapeutics, Inc. | 59 |
3 |
| Samsung Display Co., Ltd. | 30585 |
2 |
| Merck Sharp & Dohme Corp. | 2247 |
2 |
| Bayer Pharma AG | 1096 |
2 |
| Other owners | 94 |